本页面由Tiger Trade Technology Pte. Ltd.提供服务

Crescent Biopharma Inc

12.99
-1.4700-10.17%
成交量:14.89万
成交额:201.59万
市值:4.82亿
市盈率:-1.75
高:14.67
开:14.46
低:12.94
收:14.46
52周最高:27.41
52周最低:8.72
股本:3,714.39万
流通股本:1,595.35万
量比:0.32
换手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
净资产收益率:-160.75%
总资产收益率:-69.15%
市净率:6.65
市盈率(LYR):-1.01

数据加载中...

2026/09/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/15

重要事件披露

Form 8-K - Current report
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/22

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/14

SEC问询函

Form CORRESP - Correspondence